Amyloidosis Global Clinical Trials Review, H1, 2014

GlobalData
May 5, 2014
110 Pages - GLDATA18047
$2,500.00

Summary

GlobalData's clinical trial report, “Amyloidosis Global Clinical Trials Review, H1, 2014" provides data on the Amyloidosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Amyloidosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Amyloidosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

'

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Amyloidosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Amyloidosis to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Amyloidosis to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Amyloidosis 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Amyloidosis Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Amyloidosis 33
Jan 09, 2014: BELLUS Health provides update on KIACTA Phase III orphan drug study 33
Dec 24, 2013: Widely-used anti-inflammatory drug shows success in treatment of amyloidosis 33
Dec 16, 2013: Alnylam Initiates Phase II Clinical Trial with ALN-TTRsc, a Subcutaneously Delivered RNAi Therapeutic Targeting Transthyretin in Development for the Treatment of TTR-Mediated Amyloidosis 34
Nov 10, 2013: Alnylam Reports Positive Phase II Data for Patisiran, an RNAi Therapeutic Targeting Transthyretin for the Treatment of TTR-Mediated Amyloidosis, and Initiates Phase III Trial 35
Sep 30, 2013: Alnylam Completes Enrollment of Phase II Clinical Trial and Initiates Open-Label Extension (OLE) Study with ALN-TTR02, an RNAi Therapeutic Targeting Transthyretin for the Treatment of Transthyretin-Mediated Amyloidos 37
Clinical Trial Profiles 39
Clinical Trial Overview of Top Companies 39
Pfizer Inc. 39
Clinical Trial Overview of Pfizer Inc. 39
Alnylam Pharmaceuticals, Inc. 40
Clinical Trial Overview of Alnylam Pharmaceuticals, Inc. 40
Celgene Corporation 41
Clinical Trial Overview of Celgene Corporation 41
GlaxoSmithKline plc 42
Clinical Trial Overview of GlaxoSmithKline plc 42
Takeda Pharmaceutical Company Limited 43
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 43
Isis Pharmaceuticals, Inc. 44
Clinical Trial Overview of Isis Pharmaceuticals, Inc. 44
Prothena Corporation plc 45
Clinical Trial Overview of Prothena Corporation plc 45
Bellus Health Inc. 46
Clinical Trial Overview of Bellus Health Inc. 46
C.T. Development America, Inc. 47
Clinical Trial Overview of C.T. Development America, Inc. 47
Clinical Trial Overview of Top Institutes / Government 48
Boston Medical Center 48
Clinical Trial Overview of Boston Medical Center 48
Mayo Clinic 49
Clinical Trial Overview of Mayo Clinic 49
National Cancer Institute 50
Clinical Trial Overview of National Cancer Institute 50
Stanford University 51
Clinical Trial Overview of Stanford University 51
Boston University 52
Clinical Trial Overview of Boston University 52
IRCCS Policlinico San Matteo 53
Clinical Trial Overview of IRCCS Policlinico San Matteo 53
IRCCS Policlinico S. Donato 54
Clinical Trial Overview of IRCCS Policlinico S. Donato 54
Memorial Sloan Kettering Cancer Center 55
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 55
Umea University 56
Clinical Trial Overview of Umea University 56
Southwest Oncology Group 57
Clinical Trial Overview of Southwest Oncology Group 57
Five Key Clinical Profiles 58
Appendix 108
Abbreviations 108
Definitions 108
Research Methodology 109
Secondary Research 109
About GlobalData 110
Contact Us 110
Disclaimer 110
Source 110

List of Tables
Amyloidosis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Amyloidosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Amyloidosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Amyloidosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Amyloidosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Amyloidosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Amyloidosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Amyloidosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Amyloidosis to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Amyloidosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Amyloidosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Amyloidosis to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Amyloidosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Amyloidosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Amyloidosis Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Amyloidosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Amyloidosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Amyloidosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Amyloidosis Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Amyloidosis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Amyloidosis Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Amyloidosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Amyloidosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Amyloidosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Amyloidosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Amyloidosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Amyloidosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 39
Amyloidosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alnylam Pharmaceuticals, Inc., 2014* 40
Amyloidosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014* 41
Amyloidosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 42
Amyloidosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 43
Amyloidosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Isis Pharmaceuticals, Inc., 2014* 44
Amyloidosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Prothena Corporation plc, 2014* 45
Amyloidosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bellus Health Inc., 2014* 46
Amyloidosis Therapeutics Clinical Trials Market, Global, Clinical Trials by C.T. Development America, Inc., 2014* 47
Amyloidosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Medical Center, 2014* 48
Amyloidosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 49
Amyloidosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 50
Amyloidosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 51
Amyloidosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston University, 2014* 52
Amyloidosis Therapeutics Clinical Trials Market, Global, Clinical Trials by IRCCS Policlinico San Matteo, 2014* 53
Amyloidosis Therapeutics Clinical Trials Market, Global, Clinical Trials by IRCCS Policlinico S. Donato, 2014* 54
Amyloidosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 55
Amyloidosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Umea University, 2014* 56
Amyloidosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2014* 57

List of Figures
Amyloidosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Amyloidosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Amyloidosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Amyloidosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Amyloidosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Amyloidosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Amyloidosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Amyloidosis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Amyloidosis to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Amyloidosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Amyloidosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Amyloidosis to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Amyloidosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Amyloidosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Amyloidosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Amyloidosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Amyloidosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Amyloidosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Amyloidosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Amyloidosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Amyloidosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Amyloidosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Amyloidosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 109

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Custom Research

Need a custom report
tailored to your goals and budget? 

E-mail us your project outline
or call Client Services to speak
with your industry analyst.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Discount Codes

Request Discount Codes
for reports of interest to you.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax